“…Besides thermal stability, colloidal stability is an important factor to be addressed during developability assessment. 98,111,112 Colloidal interactions can be the common cause for low solubility, high viscosity, phase separation, off-target binding, and fast antibody clearance. 45,46,111,113 For some biotherapeutics, high protein concentrations of up to 200 mg/mL and above are desired, for example, if subcutaneous or intravitreous injection is the intended administration route.…”